CDEK by Data4ThePeople
Sign in Sign up
← All drugs Report issue

bax930

Recombinant proteinexperimental

Clinical trial activity

2 trials · 2 clinical orgs · 0 marketing orgs

Phase 1
1
Phase 2
1
Phase 3
1
Phase 4
0

Earliest trial started Sep 1, 2014 (NCT02216084)

Timeline

2010s

  1. Jan 1, 2014

    Earliest Phase 1 Sponsor(trial)

  2. Jan 1, 2017

    Earliest Phase 3 Sponsor(trial)

Indications

Studied for

Mechanism of action

Chemistry & pharmacology

Multi-specific
No

Oral

No

Parenteral

No

Topical

No

Also known as

  • adamts13

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT03393975Phase 3Oct 20, 2017Shire
NCT02216084Phase 1Sep 1, 2014Baxalta
Showing 2 of 2 trials
Page 1 / 1

Organizations

Research & Development (2)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
BaxaltaFor profit1112014
ShireFor profit1112017
2 organizations
Page 1 / 1